Nasal Potential Difference (NPD) Protocol in Chronic Rhinosinusitis
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- University of Alabama at Birmingham
- Study ID
- NCT02038166
- Status
- Recruiting
Conditions
- Rhinosinusitis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The purpose of this study is to determine if acquired (partial) Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) deficiency contributes substantially to the pathogenic mechanisms underlying Chronic Rhinosinusitis (CRS), creating a localized environment that impairs mucociliary clearance (MCC).
Key Dates
- Start date
- Jan 31, 2015
- Status verified
- Mar 2026
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 20 participants (estimated)
Primary Outcome Measure
Measurable Difference in CFTR function [ Time Frame: One Year ]
Central Contacts
- Norma Miller, RN(205) 975-6169
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35244 |
Find similar trials in Birmingham, AL
By research site
Related Studies
- Longitudinal Deep Phenotyping of Central Mechanisms in Dysosmia: A Pilot Study Using Electrobulbogram (EBG), Functional MRI (fMRI), and Diffusion-Weighted Imaging (DWI)Not Yet Recruiting · National Institute on Deafness and Other Communication Disorders (NIDCD) · Bethesda, Maryland